Find clinical trials for stomach cancer. Search for stomach cancer clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 180
Active & Responsive
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Duarte CA, Glendale CA, Los Angeles CA, Murrieta CA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase1, Phase2, Recruiting
Active & Responsive
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
for
Esophageal Adenocarcinoma, Gastric Adenocarcinoma
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18+
Code: NCT04150640
Phase2, Recruiting
New
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
for
Non Small Cell Lung Cancer, Cervical Cancer,
Location: Huntersville NC, Nashville TN
Sponsor: Rondo Therapeutics
Sex: All
Age: 18+
Code: NCT07218003
Phase1, Recruiting
New
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
for
Non Small Cell Lung Cancer, Esophageal Cancer, Gastric Cancer,
Location: Columbia MO
Sponsor: University of Missouri-Columbia
Sex: All
Age: 18+
Code: NCT03551951
Recruiting
A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation
for
Gastric Cancer, Stomach Cancer
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT04308837
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Avutometinib and Defactinib in Diffuse Gastric Cancer
for
Gastric Cancer, Stomach Cancer
Location: New York NY
Sponsor: Ryan H. Moy, MD, PhD
Sex: All
Age: 18+
Code: NCT06487221
Phase2, Recruiting
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
for
Brain Cancer, Breast Cancer, Bladder Cancer, Cervical Cancer,
Location: Duarte CA, Miami FL, Gainesville GA, New Albany IN,
Sponsor: Adela, Inc
Sex: All
Age: 40+
Code: NCT05366881
Recruiting
Brodalumab in the Treatment of Immune-Related Adverse Events
for
Breast Cancer, Esophageal Cancer, Kidney Cancer, Lung Cancer,
Location: New York NY
Sponsor: Brian Henick, MD
Sex: All
Age: 18+
Code: NCT06673329
Phase1, Recruiting
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer